Leadership Overview
Intas has 10 executives leading key functions including strategy, operations, marketing, finance, quality, sales, human resources, animal health, legal, and business development.
Committed to advancing global healthcare through rigorous research and manufacturing, Intas delivers high-quality pharmaceutical solutions while maintaining a focus on innovation and operational excellence across international markets.
Committed to advancing global healthcare through rigorous research and manufacturing, Intas delivers high-quality pharmaceutical solutions while maintaining a focus on innovation and operational excellence across international markets.
Leadership Roles at Intas
Rathi Jeetesh - Chief Executive Officer
Rathi Jeetesh, the Chief Executive Officer at Intas, directs the overarching corporate strategy and long-term vision for the organization. Overseeing the integration of research and manufacturing capabilities, the Chief Executive Officer ensures alignment between scientific advancement and commercial objectives. This leadership role involves navigating complex regulatory landscapes while expanding the global footprint of the company. By fostering a culture of innovation, Rathi Jeetesh drives the development of high-quality pharmaceutical products that address critical patient needs. The Chief Executive Officer maintains close collaboration with the Board to optimize resource allocation and sustain competitive advantages in the global market. Through disciplined oversight of all business units, Jeetesh secures the financial health and operational integrity of the enterprise, ensuring that the company remains a leader in the pharmaceutical sector while delivering consistent value to stakeholders and patients worldwide.
Abhimanyu Ojha - Global Chief Financial Officer & Global President, Finance
Abhimanyu Ojha, the Global Chief Financial Officer & Global President, Finance at Intas, directs the financial planning, capital allocation, and fiscal reporting for the entire organization. Overseeing global financial operations, the Global Chief Financial Officer & Global President, Finance ensures the stability and growth of the company through rigorous risk management and investment strategies. This leadership role involves managing complex financial structures across multiple international jurisdictions to support the research and manufacturing goals of the business. By optimizing capital efficiency, Abhimanyu Ojha provides the necessary resources for innovation and market expansion. The Global Chief Financial Officer & Global President, Finance collaborates with the executive team to align financial performance with long-term corporate objectives. Through precise financial oversight, Ojha secures the economic foundation of the company, ensuring that all fiscal activities contribute to sustainable growth and the continued delivery of high-quality pharmaceutical products to global markets.
Kirti Maheshwari - Chief Operating Officer
Kirti Maheshwari, the Chief Operating Officer at Intas, manages the end-to-end manufacturing processes and supply chain logistics. Overseeing the production facilities, the Chief Operating Officer optimizes operational efficiency to meet the rigorous demands of the global pharmaceutical market. This leadership role involves streamlining internal workflows and coordinating with cross-functional teams to ensure seamless product delivery. By implementing advanced manufacturing technologies, Kirti Maheshwari enhances output quality and reduces lead times across all production lines. The Chief Operating Officer monitors performance metrics to identify areas for process improvement and cost reduction. Through strategic management of industrial assets, Maheshwari supports the company mission of providing accessible healthcare solutions. The Chief Operating Officer maintains high standards of operational excellence, ensuring that all manufacturing activities comply with international safety and quality regulations while supporting the broader growth objectives of the organization.
Avinash Joshi - President, Quality
Avinash Joshi, the President, Quality at Intas, governs the quality assurance and regulatory compliance frameworks across all manufacturing and research operations. Overseeing the implementation of global quality standards, the President, Quality ensures that every product meets stringent safety and efficacy requirements. This leadership role involves managing internal audits and coordinating with regulatory bodies to maintain the highest levels of operational integrity. By fostering a culture of continuous improvement, Avinash Joshi mitigates risks and enhances the reliability of pharmaceutical production processes. The President, Quality collaborates with the executive team to integrate quality metrics into the core business strategy, ensuring that the company maintains its reputation for excellence. Through rigorous oversight of quality control systems, Joshi protects the interests of patients and stakeholders, ensuring that all operations adhere to international pharmaceutical standards while supporting the overall mission of the organization.
Venugopal Vijayendran - President, Marketing & Sales (India)
Venugopal Vijayendran, the President, Marketing & Sales (India) at Intas, directs the commercial strategy and sales operations within the domestic market. Overseeing the distribution networks and regional sales teams, the President, Marketing & Sales (India) ensures that pharmaceutical products reach healthcare providers and patients efficiently. This leadership role involves analyzing local market dynamics to tailor marketing campaigns and drive revenue growth. By optimizing the sales funnel, Venugopal Vijayendran increases market share and strengthens the presence of the company in the region. The President, Marketing & Sales (India) collaborates with other departments to ensure that product availability meets demand and that marketing messaging aligns with the core values of the organization. Through strategic management of the domestic sales force, Vijayendran supports the company mission of improving health outcomes, ensuring that the company remains a dominant force in the Indian pharmaceutical landscape.
Ajay Tiwari - President, Human Resources
Ajay Tiwari, the President, Human Resources at Intas, manages the talent acquisition, organizational development, and employee engagement strategies. Overseeing the workforce planning, the President, Human Resources ensures that the company attracts and retains the top talent necessary to drive pharmaceutical innovation. This leadership role involves designing training programs and performance management systems that align with the strategic goals of the organization. By fostering a collaborative and inclusive work environment, Ajay Tiwari enhances productivity and supports the professional growth of the staff. The President, Human Resources collaborates with the executive team to ensure that the organizational structure supports the operational needs of the business. Through effective human capital management, Tiwari strengthens the internal capabilities of the company, ensuring that the workforce remains motivated and equipped to meet the evolving challenges of the global pharmaceutical industry.
Vijay Teng - Global President, Animal Health & Fertility
Vijay Teng, the Global President, Animal Health & Fertility at Intas, directs the research, development, and commercialization of specialized veterinary and fertility products. Overseeing the expansion of these niche segments, the Global President, Animal Health & Fertility ensures that the company provides innovative solutions for animal care and reproductive health. This leadership role involves managing global distribution and identifying new market opportunities to scale the impact of these specialized divisions. By coordinating with research teams, Vijay Teng drives the development of advanced therapies that address specific health needs in the animal and fertility sectors. The Global President, Animal Health & Fertility collaborates with the executive team to align these specialized operations with the broader corporate strategy. Through strategic oversight of these divisions, Teng enhances the portfolio of the company, ensuring that the organization remains a leader in both animal health and fertility markets globally.
C. Yagnik - President, Legal
C. Yagnik, the President, Legal at Intas, manages the legal affairs, intellectual property protection, and regulatory compliance for the entire organization. Overseeing the legal strategy, the President, Legal ensures that all business activities adhere to international laws and industry regulations. This leadership role involves mitigating legal risks and managing complex litigation or contract negotiations that arise from global pharmaceutical operations. By providing expert counsel, C. Yagnik supports the strategic initiatives of the company and protects the intellectual assets of the business. The President, Legal collaborates with the executive team to ensure that all corporate actions are legally sound and aligned with the long-term objectives of the organization. Through diligent oversight of legal matters, Yagnik secures the operational integrity of the company, ensuring that the business can continue to innovate and expand in a highly regulated global environment.
Giridhar Venugopal - President, Emerging Markets & Bd
Giridhar Venugopal, the President, Emerging Markets & Bd at Intas, directs the expansion into high-growth international regions and manages strategic business development initiatives. Overseeing the entry into new territories, the President, Emerging Markets & Bd identifies and executes partnerships that broaden the global reach of the company. This leadership role involves analyzing market potential and navigating the unique regulatory and commercial challenges of emerging economies. By driving business development, Giridhar Venugopal secures new revenue streams and enhances the competitive position of the organization. The President, Emerging Markets & Bd collaborates with the executive team to ensure that international expansion aligns with the overall growth strategy of the company. Through strategic management of emerging markets, Venugopal supports the mission of the organization, ensuring that the company successfully delivers pharmaceutical solutions to diverse populations across the globe.
Anshu Verma - Senior General Manager, External Manufacturing (Chief Marketing Officer and CDMO)
Anshu Verma, the Senior General Manager, External Manufacturing (Chief Marketing Officer and CDMO) at Intas, architects the commercial strategy and external manufacturing partnerships. Overseeing the expansion of contract development and manufacturing services, the Senior General Manager, External Manufacturing (Chief Marketing Officer and CDMO) drives market penetration and brand positioning. This leadership role involves cultivating relationships with global partners to scale production capabilities and broaden the reach of pharmaceutical offerings. By analyzing market trends, Anshu Verma identifies new opportunities for growth and service diversification. The Senior General Manager, External Manufacturing (Chief Marketing Officer and CDMO) coordinates with internal teams to ensure that marketing initiatives align with the technical strengths of the company. Through strategic oversight of external manufacturing operations, Verma enhances the competitive standing of the organization, ensuring that the company remains a preferred partner for pharmaceutical development and production on a global scale.
Explore Leadership Teams in Manufacturing
Astellas Pharma is engaged in the manufacturing, marketing, import, and export of pharmaceuticals. It is headquartered in Tokyo, Japan.
Company Leadership RT
MB
KS
AK
Fresenius Kabi, a subsidiary of Fresenius, is a global health care company that specializes in medicines and technologies for infusion, transfusion, and clinical nutrition. Fresenius Kabi is headquartered in Bad Homburg, Germany with locations around the world.
Company Leadership MV
SM
CM
RT
Founded in 1974, Accupac is headquartered in Mainland, Pennsylvania. They provide outsourced manufacturing and packaging solutions to pharmaceutical and over-the-counter personal care product manufacturers.
Company Leadership DR
JW
KG
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. Its marketed products include ONPATTRO (patisiran) for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; AMVUTTRA for the treatment of hATTR amyloidosis with polyneuropathy in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria; and OXLUMO for the treatment of primary hyperoxaluria type 1. In addition, the company develops patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; cemdisiran to treat complement-mediated diseases; Belcesiran for the treatment of alpha-1 liver disease; Elebsiran to treat chronic HBV infection; Zilebesiran to treat hypertension; ALN-APP to treat Alzheimer's disease and cerebral amyloid angiopathy; and ALN-HSD to treat NASH. Further, it offers Fitusiran for the treatment of hemophilia, Inclisiran to treat hypercholesterolemia, lumasiran for the treatment of advanced PH1, and vutrisiran for the treatment of ATTR amyloidosis, which is in phase 3 clinical trial. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Roche to develop pharmaceutical products containing zilebesiran. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
Company Leadership
CC
BS
SR
Frequently Asked Questions Regarding Intas Top Executives and Leadership Team
